A Verisyse phakic intraocular lens (pIOL) (AMO) was implanted in the eye of a 3-year-old child with unilateral high myopia and suspected dense amblyopia. Four years postoperatively, the Snellen visual acuity was 20/30 with a refraction of -1.00 -1.00 x 77 and the endothelial cell density was 3262 cells/mm(2) compared with 3092 cells/mm(2) in the right eye. The Verisyse pIOL may be a treatment option to prevent dense amblyopia in children with highly myopic anisometropia.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcrs.2007.06.038DOI Listing

Publication Analysis

Top Keywords

intraocular lens
8
dense amblyopia
8
verisyse intraocular
4
lens implantation
4
implantation child
4
child anisometropic
4
anisometropic amblyopia
4
amblyopia four-year
4
four-year follow-up
4
follow-up verisyse
4

Similar Publications

This research was designed to evaluate the efficacy and safety of ab-interno trabeculectomy (Trabectome and Kahook Dual Blade) combined with phacoemulsification, intraocular lens implantation, and goniosynechialysis in eyes with primary angle-closure glaucoma. A total of 47 patients were included in the study and all the patients received the combined surgery. Intraocular pressure, anti-glaucoma medications, best-corrected visual acuity, and the number of peripheral anterior synechiae quadrants were recorded at baseline and at various time points after surgery.

View Article and Find Full Text PDF

This study aims to analyze the prevalence and severity of posterior capsule opacification (PCO) and glistening in a new hydrophobic biaspheric monofocal intraocular lens (IOLs) 24 months after implantation. By means of a ambispective, observational, case-control design, a total of 297 eyes from 200 cataract surgery patients were included in the study (118 females and 82 males; mean age: 72.31 ± 9.

View Article and Find Full Text PDF

Purpose: To evaluate the accuracy of toric intraocular lens (IOL) axis prediction between two preoperative measurement devices: the optical biometry (IOLMaster 500 or 700) and the dual Scheimpflug topography (Galilei G4).

Methods: Medical records of 64 eyes from 44 patients who underwent phacoemulsification and posterior chamber toric IOL (Zeiss AT TORBI 709M) implantation between July 2017 and January 2022 were reviewed. All patients underwent preoperative evaluation by optical biometry (IOLMaster 500 or IOLMaster 700) and Galilei G4.

View Article and Find Full Text PDF

Potential guidelines for cataract surgery and rehabilitation in visually impaired patients: Literature analysis.

Aging Med (Milton)

December 2024

Department of Sense Organs, Faculty of Medicine and Odontology, Rare Retinal Diseases and Ocular Electrophysiology Centre, Umberto I Policlinic Sapienza University of Rome Rome Italy.

Cataracts can reduce the quality of vision in visually impaired patients who already have a visual impairment. The most common causes of low vision include age-related macular degeneration (AMD), high myopia (HM), diabetic retinopathy (DR), glaucoma (GL), and inherited degenerative ocular diseases. The surgery aims to improve their independence, quality of life, and ability to engage in daily, social, and work activities.

View Article and Find Full Text PDF

Objectives This study aimed to identify the etiology and the direction of dislocation of the natural crystalline lens or intraocular lens (IOL) in IOL intrascleral fixation surgery and to determine the change in intraocular pressure (IOP) after surgery. Methods We retrospectively investigated the diagnosis, direction of lens and IOL dislocation, and IOP before and after surgery (preoperatively and one day, one week, and one month postoperatively) in 236 eyes from 228 patients who underwent IOL intrascleral fixation at Chiba University Hospital between February 2015 and September 2020. Results IOL intrascleral fixation was performed in 48 (20.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!